News

Canada Adopts First-Ever Rare Disease Strategy

Publish date: June 11, 2015

 

References

Canada has adopted its first-ever nationwide Rare Disease Strategy with five key goals to improve care and treatment of rare disorders. The goals are: improving early detection and prevention, providing better care, enhancing community support, providing access to promising therapies, and promoting innovative research. Read the executive summary provided by the Canadian Organization for Rare Disorders (CORD).

http://www.raredisorders.ca/documents/WEBENFinalExecSummaryMay232015.pdf


Recommended Reading

NORD to honor NIH Director and others at Portraits of Courage Celebration
MDedge Neurology
Neurologists describe how “cyberconsults” may help those training for rare disease careers
MDedge Neurology
Genetic testing improves diagnostic yield in children with encephalopathy
MDedge Neurology
AAN and AANEM publish guides for evaluation, diagnosis and management of Congenital Muscular Dystrophy (CMD)
MDedge Neurology
AAN: Largest neuroleptic malignant syndrome study finds predictors of poor outcome
MDedge Neurology
A New Symptomatic Treatment for Lambert-Eaton Myasthenic Syndrome?
MDedge Neurology
Research Illuminates Genetic Forms of Epilepsy
MDedge Neurology
NORD Issues Statement on Approval of 21st Century Cures Initiative and Introduction of OPEN Act
MDedge Neurology
Foundation for Prader-Willi Research and NORD Launch Global Registry
MDedge Neurology
NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)
MDedge Neurology